Lista de obras - John-Patrick Mpindi - Dominio Público Uruguay

A cell spot microarray method for production of high density siRNA transfection microarrays

artículo científico publicado en 2011

A community effort to assess and improve drug sensitivity prediction algorithms.

artículo científico publicado en 2014

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses

artículo científico publicado en 2010

A functional genetic screen reveals new regulators of β1-integrin activity

artículo científico publicado en 2012

A novel transcript, VNN1-AB, as a biomarker for colorectal cancer

artículo científico publicado en 2014

ARLTS1 and prostate cancer risk--analysis of expression and regulation

artículo científico publicado en 2013

Anagrelide for Gastrointestinal Stromal Tumor

scientific article published on 07 December 2018

Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions

artículo científico publicado en 2014

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer

artículo científico publicado en 2011

Breeze: an integrated quality control and data analysis application for high-throughput drug screening

artículo científico publicado en 2020

Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours.

artículo científico publicado en 2018

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer

artículo científico publicado en 2016

Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs

artículo científico publicado en 2012

Consistency in drug response profiling

artículo científico publicado en 2016

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells

artículo científico publicado en 2011

Correction: GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets

artículo científico publicado en 2011

Correction: Plasticity of Blood- and Lymphatic Endothelial Cells and Marker Identification.

artículo científico publicado en 2013

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors

artículo científico publicado en 2017

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors

artículo científico publicado en 2017

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

artículo científico publicado en 2010

GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets

artículo científico publicado en 2011

High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells

artículo científico publicado en 2013

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion

artículo científico publicado en 2013

High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer

artículo científico publicado en 2012

ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer

artículo científico publicado en 2018

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data

artículo científico publicado en 2015

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer

artículo científico publicado en 2011

Plasticity of blood- and lymphatic endothelial cells and marker identification

artículo científico publicado en 2013

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker

artículo científico publicado en 2016

Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue

artículo científico publicado en 2015

Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues

artículo científico publicado en 2008

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer

artículo científico publicado en 2016

Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma

artículo científico publicado en 2012

The impact of low-frequency and rare variants on lipid levels

artículo científico publicado en 2015

Lista de obras de John-Patrick Mpindi

A cell spot microarray method for production of high density siRNA transfection microarrays

A community effort to assess and improve drug sensitivity prediction algorithms.

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses

A functional genetic screen reveals new regulators of β1-integrin activity

A novel transcript, VNN1-AB, as a biomarker for colorectal cancer

ARLTS1 and prostate cancer risk--analysis of expression and regulation

Anagrelide for Gastrointestinal Stromal Tumor

Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer

Breeze: an integrated quality control and data analysis application for high-throughput drug screening

Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours.

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer

Comprehensive data-driven analysis of the impact of chemoinformatic structure on the genome-wide biological response profiles of cancer cells to 1159 drugs

Consistency in drug response profiling

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells

Correction: GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets

Correction: Plasticity of Blood- and Lymphatic Endothelial Cells and Marker Identification.

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

GTI: a novel algorithm for identifying outlier gene expression profiles from integrated microarray datasets

High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion

High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer

ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer

Plasticity of blood- and lymphatic endothelial cells and marker identification

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker

Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue

Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer

Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma

The impact of low-frequency and rare variants on lipid levels